Search

Your search keyword '"Highly active antiretroviral therapy -- Demographic aspects"' showing total 9 results
Start Over Descriptor "Highly active antiretroviral therapy -- Demographic aspects" Topic highly active antiretroviral therapy -- patient outcomes
9 results on '"Highly active antiretroviral therapy -- Demographic aspects"'

1. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from AASERT study

Author

Stellbrink, Hans-Jurgen, Orkin, Chloe, Arribas, Jose Ramon, Compston, Juiet, Gerstoft, Jan, Van Wijngaerden, Eric, Lazzarin, Adriano, Rizzardini, Giuliano, Sprenger, Herman G., Lambert, John, Sture, Gunta, Leather, David, Hughes, Sara, Zucchi, Patrizia, and Pearce, Helen

Subjects
Drug therapy, Combination -- Safety and security measures, Drug therapy, Combination -- Research, Antiviral agents -- Dosage and administration, Antiviral agents -- Complications and side effects, Antiviral agents -- Research, Highly active antiretroviral therapy -- Patient outcomes, Highly active antiretroviral therapy -- Demographic aspects, Highly active antiretroviral therapy -- Research, Bones -- Density, Bones -- Comparative analysis, Bones -- Demographic aspects, Health, Health care industry
Published
2010

2. Examination of inequalities in HIV/AIDS mortality in the United States from a fundamental cause perspective

Author

Rubin, Marcie S., Colen, Cynthia G., and Link, Bruce G.

Subjects
Highly active antiretroviral therapy -- Patient outcomes, Highly active antiretroviral therapy -- Demographic aspects, Highly active antiretroviral therapy -- Health aspects, HIV infection -- Drug therapy, HIV infection -- Demographic aspects, HIV infection -- Patient outcomes, HIV infection -- Research, Discrimination in medical care -- Demographic aspects, Mortality -- United States, Mortality -- Risk factors, Mortality -- Research, Government, Health care industry
Abstract

Objectives. We examined changes in socioeconomic status (SES) and Black to White inequalities in HIV/AIDS mortality in the United States before and after the introduction of highly active antiretroviral therapy (HAART). Methods. Taking a fundamental cause perspective, we used negative binomial regression to analyze trends in county-level gender-, race-, and age-specific HIV/ AIDS mortality rates among those aged 15 to 64 years during the period 1987-2005. Results. Although HIV/AIDS mortality rates decreased once HAART became available, the declines were not uniformly distributed among population groups. The associations between SES and HIV/AIDS mortality and between race and HIV/AIDS mortality, although present in the pre-HAART period, were significantly greater in the peri- and post-HAART periods, with higher SES and White race associated with the greatest declines in mortality during the post-HAART period. Conclusions. Our findings support the fundamental cause hypothesis, as the introduction of a life-extending treatment exacerbated inequalities in HIV/AIDS mortality by SES and by race. In addition to a strong focus on factors that improve overall population health, more effective public health interventions and policies would facilitate an equitable distribution of health-enhancing innovations. (Am J Public Health. 2010;100:1053-1059. doi: 10.2105/AJPH.2009.170241)

Published
2010

3. Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort

Author

Collini, Paul, Schwab, Uli, Sarfo, Stephen, Obeng-Baah, Joseph, Norman, Betty, Chadwick, David, Bibby, David, and Bedu-Addo, George

Subjects
Immune response -- Demographic aspects, Immune response -- Research, Highly active antiretroviral therapy -- Dosage and administration, Highly active antiretroviral therapy -- Patient outcomes, Highly active antiretroviral therapy -- Demographic aspects, Highly active antiretroviral therapy -- Research, Health, Health care industry
Published
2009

4. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program

Author

Hoffmann, Christopher J., Charalambous, Salome, Martin, Desmond J., Innes, Craig, Churchyard, Gavin J., Chaisson, Richard E., Grant, Alison D., Fielding, Katherine L., and Thio, Chloe L.

Subjects
Hepatitis B -- Care and treatment, Hepatitis B -- Patient outcomes, Hepatitis B -- Research, Antiviral agents -- Dosage and administration, Highly active antiretroviral therapy -- Patient outcomes, Highly active antiretroviral therapy -- Demographic aspects, Highly active antiretroviral therapy -- Reports, Health, Health care industry
Published
2008

5. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study

Author

Patel, Kunjal, Hernan, Miguel A., Williams, Paige L., Seeger, John D., McIntosh, Kenneth, Van Dyke, Russell B., and Seage, George R., III

Subjects
Highly active antiretroviral therapy -- Demographic aspects, Highly active antiretroviral therapy -- Patient outcomes, Highly active antiretroviral therapy -- Research, HIV infection in children -- Care and treatment, HIV infection in children -- Patient outcomes, HIV infection in children -- Research, Health, Health care industry
Published
2008

6. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intrapeithelial lesions in human immunodeficiency virus-positive women

Author

Minkoff, Howard, Zhong, Ye, Burk, Robert D., Palefsky, Joel M., Xue, Xiaonan, Watts, D. Heather, Levine, Alexandra M., Wright, Rodney L., Colie, Christine, D'Souza, Gypsyamber, Massad, L. Stewart, and Strickler, Howard D.

Subjects
Highly active antiretroviral therapy -- Patient outcomes, Highly active antiretroviral therapy -- Research, Highly active antiretroviral therapy -- Demographic aspects, HIV infection -- Care and treatment, HIV infection -- Complications and side effects, HIV infection -- Patient outcomes, HIV infection -- Research, Patient compliance -- Influence, Patient compliance -- Research, Papillomavirus infections -- Prevention, Papillomavirus infections -- Research, Cervix dysplasia -- Prevention, Cervix dysplasia -- Research, Health
Published
2010

7. Five-year outcomes of the China National Free Antiretroviral Treatment Program

Author

Zhang, Fujie, Dou, Zhihui, Ma, Ye, Zhao, Yan, Liu, Zhongfu, Bulterys, Marc, and Chen, Ray Y.

Subjects
AIDS (Disease) -- Care and treatment, AIDS (Disease) -- Patient outcomes, AIDS (Disease) -- Demographic aspects, AIDS (Disease) -- Research, Highly active antiretroviral therapy -- Patient outcomes, Highly active antiretroviral therapy -- Demographic aspects, Highly active antiretroviral therapy -- Research, Immunotherapy -- Health aspects, Immunotherapy -- Patient outcomes, Immunotherapy -- Research, Health
Abstract

Background: China's National Free Antiretroviral Treatment Program began in 2002 and, by August 2008, included more than 52 000 patients. Objective: To report 5-year outcomes on adult mortality and immunologic treatment failure rates and risk factors. Design: Open cohort analysis of a prospectively collected, observational database. Setting: China. Patients: All patients in the national treatment database from June 2002 to August 2008. Patients were excluded if they had not started triple therapy or had missing treatment regimen information. Intervention: Antiretroviral therapy according to Chinese national treatment guidelines. Measurements: Mortality rate and immunologic treatment failure rate, according to World Health Organization criteria. Results: Of 52 191 patients, 48 785 were included. Median age was 38 years, 58% were men, 53% were infected through plasma or blood, and the median baseline CD4 cell count was 0.118 x [10.sup.9] cells/L. Mortality was greatest during the first 3 months of treatment (22.6 deaths per 100 person-years) but decreased to a steady rate of 4 to 5 deaths per 100 person-years after 6 months and maintained this rate over the subsequent 4.5 years. The strongest mortality risk factors were a baseline CD4 cell count less than 0.050 x [10.sup.9] cells/L (adjusted hazard ratio [HR] compared with a count [greater than or equal to] 0.200 x [10.sup.9] cells/L, 3.3 [95% CI, 2.9 to 3.8]) and having 4 to 5 baseline symptom categories (adjusted HR compared with no baseline symptom categories, 3.4 [CI, 2.9 to 4.0]). Treatment failure was determined among 31 070 patients with 1 or more follow-up CD4 cell counts. Overall, treatment failed for 25% of patients (12.0 treatment failures per 100 person-years), with the cumulative treatment failure rate increasing to 50% at 5 years. Limitation: Immunologic treatment failure does not necessarily correlate well with virologic treatment failure. Conclusion: The National Free Antiretroviral Treatment Program reduced mortality among adult patients in China with AIDS to rates similar to those of other low- or middle-income countries. A cumulative immunologic treatment failure rate of 50% after 5 years, due to the limited availability of second-line regimens, is of great concern. Primary Funding Source: China Ministry of Health, U.S. National Institutes of Health, and U.S. Centers for Disease Control and Prevention Global AIDS Program.

Published
2009

8. Protective effect of HIV-positive primary caregivers on mortality in children receiving antiretroviral therapy?

Author

Moultrie, Harry and Meyers, Tammy

Subjects
HIV seropositivity -- Influence, Highly active antiretroviral therapy -- Demographic aspects, Highly active antiretroviral therapy -- Patient outcomes, Highly active antiretroviral therapy -- Research, HIV infection in children -- Care and treatment, HIV infection in children -- Patient outcomes, HIV infection in children -- Research, Health
Published
2008

9. HIV Therapy Linked to Fewer Suicides; Better mental health care still needed for those with the virus, expert says

Subjects
HIV patients -- Care and treatment, HIV patients -- Psychological aspects, Highly active antiretroviral therapy -- Health aspects, Highly active antiretroviral therapy -- Patient outcomes, Highly active antiretroviral therapy -- Demographic aspects, Highly active antiretroviral therapy -- Research, Suicide -- Risk factors, Suicide -- Prevention, Suicide -- Demographic aspects, Suicide -- Research
Abstract

TUESDAY, Dec. 15 (HealthDay News) -- Suicides among people in Switzerland who were infected with HIV decreased by more than half after the introduction of highly active antiretroviral therapy in [...]

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results